146 related articles for article (PubMed ID: 30963002)
1. Effect of second primary cancer on the prognosis of patients with non-small cell lung cancer.
Wu B; Cui Y; Tian J; Song X; Hu P; Wei S
J Thorac Dis; 2019 Feb; 11(2):573-582. PubMed ID: 30963002
[TBL] [Abstract][Full Text] [Related]
2. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
3. The Valuable Prognostic Impact of Regional Lymph Node Removed on Outcomes for IIIA N0 NSCLC Patients.
Wang Y; Liu Z; Zhou Z; Rao H; Xiong J; Xie S
J Cancer; 2023; 14(11):2093-2108. PubMed ID: 37497411
[No Abstract] [Full Text] [Related]
4. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
Ren Y; Dai C; Shen J; Liu Y; Xie D; Zheng H; He J; Liang W; Jiang G; Fei K; Yang P; He J; Chen C
Oncotarget; 2016 May; 7(18):26856-65. PubMed ID: 27057627
[TBL] [Abstract][Full Text] [Related]
5. Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
Wei S; Tian J; Song X; Wu B; Liu L
J Cancer Res Clin Oncol; 2018 Jan; 144(1):145-155. PubMed ID: 28980067
[TBL] [Abstract][Full Text] [Related]
6. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
[TBL] [Abstract][Full Text] [Related]
7. Radical local treatment for stage IV non-small cell lung cancer in older adults: a propensity-score matched analysis of the SEER database.
Qiu C; Zhang S; Jin H; Zhang X; Ye J
Transl Cancer Res; 2020 Sep; 9(9):5336-5349. PubMed ID: 35117899
[TBL] [Abstract][Full Text] [Related]
8. Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors.
Bailey S; Ezratty C; Mhango G; Lin JJ
Breast Cancer; 2023 Mar; 30(2):215-225. PubMed ID: 36316601
[TBL] [Abstract][Full Text] [Related]
9. Lobectomy Can Improve the Survival of Patients With Non-small Cell Lung Cancer With Lung Oligometastatic.
Wang L; Jiao F; Dong L; Li Q; Liu G; Hu X
Front Surg; 2021; 8():685186. PubMed ID: 34291078
[No Abstract] [Full Text] [Related]
10. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
11. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
Wu L; Zhao W; Chen T; Yang Y
J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
[TBL] [Abstract][Full Text] [Related]
12. Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database.
Moreno AC; Morgensztern D; Yu JB; Boffa DJ; Decker RH; Detterbeck FC; Kim AW
J Surg Res; 2013 Sep; 184(1):10-8. PubMed ID: 23583079
[TBL] [Abstract][Full Text] [Related]
13. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
Budnik J; DeNunzio NJ; Singh DP; Milano MT
Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310
[TBL] [Abstract][Full Text] [Related]
14. Second primary cancers and survival among neuroendocrine tumor patients.
Bateni SB; Coburn NG; Law C; Singh S; Myrehaug S; Assal A; Hallet J
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37184947
[TBL] [Abstract][Full Text] [Related]
15. Life-long follow-up of second primary lung and extra-pulmonary cancer in lung cancer patients is needed.
Ma B; Qin G; Zhang Y; Su C; Wu Z
J Cancer; 2020; 11(16):4709-4715. PubMed ID: 32626517
[No Abstract] [Full Text] [Related]
16. Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer.
Hao B; Zhang L; Fan T; Liu B; Jiang W; Hu H; Geng Q
Front Oncol; 2020; 10():661. PubMed ID: 32500023
[No Abstract] [Full Text] [Related]
17. Survival comparison of right and left side non-small cell lung cancer in stage I-IIIA patients: A Surveillance Epidemiology and End Results (SEER) analysis.
Jia B; Zheng Q; Qi X; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Zhao X; Yang X; Zhong J; Chen H; Dong Z; Shi Y; Du F; Wang J; Chi Y; Zhai X; Wang Z
Thorac Cancer; 2019 Mar; 10(3):459-471. PubMed ID: 30628193
[TBL] [Abstract][Full Text] [Related]
18. Influence of family history on risk of second primary cancers and survival in patients with squamous cell skin cancer.
Chattopadhyay S; Zheng G; Hemminki A; Försti A; Sundquist K; Sundquist J; Hemminki K
Br J Dermatol; 2020 Sep; 183(3):488-494. PubMed ID: 31853941
[TBL] [Abstract][Full Text] [Related]
19. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer.
Chattopadhyay S; Hemminki O; Försti A; Sundquist K; Sundquist J; Hemminki K
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):143-149. PubMed ID: 30185889
[TBL] [Abstract][Full Text] [Related]
20. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy.
Kawaguchi T; Matsumura A; Iuchi K; Ishikawa S; Maeda H; Fukai S; Komatsu H; Kawahara M
Jpn J Clin Oncol; 2006 Jan; 36(1):7-11. PubMed ID: 16368713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
